Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.

BMC cancer - 13 Aug 2021

Zhang Yan, Zhang Denan, Meng Qingkang, Liu Ziqi, Xie Hongbo, Liu Lei, Xu Fei, Chen Xiujie

Abstract excerpt

BACKGROUND: Breast cancer (BC) is a complex disease with high heterogeneity, which often leads to great differences in treatment results. Current common molecular typing method is PAM50, which shows positive results for precision medicine; however, room for improvement still remains because of the different prognoses of subtypes. Therefore, in this article, we used lncRNAs, which are more tissue-specific and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Computational Biology

Share to Disease Management

Share to Genetic Heterogeneity

Share to Precision Medicine

Share to RNA, Long Noncoding

Share to Single-Cell Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 34388989
DOI: 10.1186/s12885-021-08617-7
PMCID: PMC8361656

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.PMID 34388989Read ↗

Molecular subtypes and precision treatment of triple-negative breast cancerSemantic proximity Read ↗

Malignant cell related gene signature for patients with triple-negative breast cancer based on integrated analysis of single cell and bulk RNA sequencingSemantic proximity Read ↗

Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-SeqSemantic proximity Read ↗

Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer SubtypesSemantic proximity Read ↗

Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune ActivitySemantic proximity Read ↗

Individualized lncRNA differential expression profile reveals heterogeneity of breast cancerSemantic proximity Read ↗

Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy ResponseSemantic proximity Read ↗

Integrated single-cell and bulk RNA sequencing analysis identifies the predictive signature for prognosis and neoadjuvant chemotherapy responses in breast cancerSemantic proximity Read ↗

Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell dataSemantic proximity Read ↗

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune MicroenvironmentSemantic proximity Read ↗

Single-cell RNA sequencing reveals the heterogeneity of tumor-associated macrophages in three subtypes of breast cancerSemantic proximity Read ↗

Exposing the cellular situation: findings from single cell RNA sequencing in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.